Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Infections caused by Candida spp. in surgical intensive care

František Vyhnánek, J. Vranková

. 2003 ; 11 (4) : 156-159.

Language English Country Czech Republic

Mycotic infections are lastly a significant morbidity and mortality cause of critically ill patients in surgical intensive care units. The most frequent causative agents of mycotic infections in surgical patients are Candida species. In order to assess the significance of mycotic infections for the critically ill in surgical intensive care and resuscitation units a retrospective evaluation of mycotic infection incidence and of their sensitivity to antimycotics has been performed, and some risk factors occurring in patients with fungal colonization have been determined. It was shown that colonization with yeasts, and candidaemia are most frequently caused by the fungus Candida albicans (88.2 - 93 %). Colonization with yeasts occurs most frequently in the air passages and the efferent urinary tract. The lowest resistance rate of Candida spp. was noted to Amphotericin B. Among the most frequent risk factors occurring in surgical patients with yeast colonization are risks from antibiotic treatment, and from certain interventional therapeutic procedures. In case of simultaneous occurrence of risk factors and proven yeast colonization, the route of choice is prophylactic, or pre-emptive therapy with an antimycotic (fluconazole, or Amphotericin B if resistance to the former has been proven).

VII. European congress of ESS, Prague, November 20.-22.

Bibliography, etc.

Lit.: 10

000      
00000naa 2200000 a 4500
001      
bmc07518229
003      
CZ-PrNML
005      
20111210130427.0
008      
090224s2003 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Vyhnánek, František, $d 1944-2020 $7 nlk19990074033
245    10
$a Infections caused by Candida spp. in surgical intensive care / $c František Vyhnánek, J. Vranková
314    __
$a Department of Surgery, 3rd Faculty of Medicine, Charles University, Prague
500    __
$a VII. European congress of ESS, Prague, November 20.-22.
504    __
$a Lit.: 10
520    9_
$a Mycotic infections are lastly a significant morbidity and mortality cause of critically ill patients in surgical intensive care units. The most frequent causative agents of mycotic infections in surgical patients are Candida species. In order to assess the significance of mycotic infections for the critically ill in surgical intensive care and resuscitation units a retrospective evaluation of mycotic infection incidence and of their sensitivity to antimycotics has been performed, and some risk factors occurring in patients with fungal colonization have been determined. It was shown that colonization with yeasts, and candidaemia are most frequently caused by the fungus Candida albicans (88.2 - 93 %). Colonization with yeasts occurs most frequently in the air passages and the efferent urinary tract. The lowest resistance rate of Candida spp. was noted to Amphotericin B. Among the most frequent risk factors occurring in surgical patients with yeast colonization are risks from antibiotic treatment, and from certain interventional therapeutic procedures. In case of simultaneous occurrence of risk factors and proven yeast colonization, the route of choice is prophylactic, or pre-emptive therapy with an antimycotic (fluconazole, or Amphotericin B if resistance to the former has been proven).
650    _2
$a infekce $x etiologie $x farmakoterapie $x komplikace $7 D007239
650    _2
$a chirurgie operační $x škodlivé účinky $x využití $7 D013514
650    _2
$a infekce spojené se zdravotní péčí $x farmakoterapie $x komplikace $7 D003428
650    _2
$a infekce dýchací soustavy $x farmakoterapie $x klasifikace $x komplikace $7 D012141
650    _2
$a infekce močového ústrojí $x farmakoterapie $x klasifikace $x komplikace $7 D014552
650    _2
$a jednotky intenzivní péče $x využití $7 D007362
650    _2
$a péče o pacienty v kritickém stavu $x metody $x využití $7 D003422
650    _2
$a Candida $x izolace a purifikace $x patogenita $x účinky léků $7 D002175
650    _2
$a mikrobiologické techniky $x metody $x využití $7 D008828
650    _2
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a amfotericin B $x farmakokinetika $x terapeutické užití $7 D000666
650    _2
$a antifungální látky $x terapeutické užití $7 D000935
650    _2
$a lidé $7 D006801
700    1_
$a Vranková, J. $7 _AN028526
773    0_
$w MED00010968 $t Bulletin HPB $g Roč. 11, č. 4 (2003), s. 156-159 $x 1210-6755
910    __
$a ABA008 $b B 1845 $c 476 b $y 9
990    __
$a 20090221132711 $b ABA008
991    __
$a 20090226083815 $b ABA008
999    __
$a ok $b bmc $g 636041 $s 488770
BAS    __
$a 3
BMC    __
$a 2003 $b 11 $c 4 $d 156-159 $i 1210-6755 $m Bulletin HPB $x MED00010968
LZP    __
$a 2009-09/dkal

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...